An Observational Follow-Up Study of Patients Previously Enrolled in ADR-001-01 Study Against Liver Cirrhosis
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2018
At a glance
- Drugs ADR-001 (Primary)
- Indications Liver cirrhosis
- Focus Adverse reactions
- Sponsors Rohto Pharmaceutical
- 26 Nov 2018 Planned End Date changed from 31 Jul 2020 to 31 Jul 2021.
- 26 Nov 2018 Planned primary completion date changed from 31 Jul 2020 to 31 Jul 2021.
- 31 Aug 2018 Biomarkers information updated